Anti-TITIN/ TTN/ CMD1G monoclonal antibody
Anti-TITIN/ TTN/ CMD1G antibody for FACS & in-vivo assay
Go to TTN/TTN products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-MP1890-Ab-1/ GM-Tg-hg-MP1890-Ab-2 | Anti-Human TTN monoclonal antibody | Human |
GM-Tg-rg-MP1890-Ab-1/ GM-Tg-rg-MP1890-Ab-2 | Anti-Rat TTN monoclonal antibody | Rat |
GM-Tg-mg-MP1890-Ab-1/ GM-Tg-mg-MP1890-Ab-2 | Anti-Mouse TTN monoclonal antibody | Mouse |
GM-Tg-cynog-MP1890-Ab-1/ GM-Tg-cynog-MP1890-Ab-2 | Anti-Cynomolgus/ Rhesus macaque TTN monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-MP1890-Ab-1/ GM-Tg-felg-MP1890-Ab-2 | Anti-Feline TTN monoclonal antibody | Feline |
GM-Tg-cang-MP1890-Ab-1/ GM-Tg-cang-MP1890-Ab-2 | Anti-Canine TTN monoclonal antibody | Canine |
GM-Tg-bovg-MP1890-Ab-1/ GM-Tg-bovg-MP1890-Ab-2 | Anti-Bovine TTN monoclonal antibody | Bovine |
GM-Tg-equg-MP1890-Ab-1/ GM-Tg-equg-MP1890-Ab-2 | Anti-Equine TTN monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-MP1890-Ab-1/ GM-Tg-hg-MP1890-Ab-2; GM-Tg-rg-MP1890-Ab-1/ GM-Tg-rg-MP1890-Ab-2; GM-Tg-mg-MP1890-Ab-1/ GM-Tg-mg-MP1890-Ab-2; GM-Tg-cynog-MP1890-Ab-1/ GM-Tg-cynog-MP1890-Ab-2; GM-Tg-felg-MP1890-Ab-1/ GM-Tg-felg-MP1890-Ab-2; GM-Tg-cang-MP1890-Ab-1/ GM-Tg-cang-MP1890-Ab-2; GM-Tg-bovg-MP1890-Ab-1/ GM-Tg-bovg-MP1890-Ab-2; GM-Tg-equg-MP1890-Ab-1/ GM-Tg-equg-MP1890-Ab-2 |
Products Name | Anti-TTN monoclonal antibody |
Format | mab |
Target Name | TTN |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-TTN benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | Products Developing | Multi-species TITIN/ TTN/ CMD1G VLP (virus-like particle) (Products Developing) |
Target information
Target ID | GM-MP1890 |
Target Name | TTN |
Gene ID | 7273,22138,84015,703527,478820,101080315,540561,100053844 |
Gene Symbol and Synonyms | 1100001C23Rik,2310036G12Rik,2310057K23Rik,2310074I15Rik,CMD1G,CMH9,CMPD4,CMYP5,D330041I19Rik,D830007G01Rik,EOMFC,HMERF,L56,LGMD2J,LGMDR10,mdm,MYLK5,SALMY,shru,™D,TTN |
Uniprot Accession | Q8WZ42 |
Uniprot Entry Name | TITIN_HUMAN |
Protein Sub-location | Transmembrane Protein |
Category | |
Disease | Mucocutaneous lymph node syndrome [Kawasaki], Acute kidney failure |
Gene Ensembl | ENSG00000155657 |
Target Classification | N/A |
The target: TTN, gene name: TTN, also named as CMD1G, CMH9, CMPD4, EOMFC, HMERF, LGMD2J, LGMDR10, MYLK5, SALMY, ™D. This gene encodes a large abundant protein of striated muscle. The product of this gene is divided into two regions, a N-terminal I-band and a C-terminal A-band. The I-band, which is the elastic part of the molecule, contains two regions of tandem immunoglobulin domains on either side of a PEVK region that is rich in proline, glutamate, valine and lysine. The A-band, which is thought to act as a protein-ruler, contains a mixture of immunoglobulin and fibronectin repeats, and possesses kinase activity. An N-terminal Z-disc region and a C-terminal M-line region bind to the Z-line and M-line of the sarcomere, respectively, so that a single titin molecule spans half the length of a sarcomere. Titin also contains binding sites for muscle associated proteins so it serves as an adhesion template for the assembly of contractile machinery in muscle cells. It has also been identified as a structural protein for chromosomes. Alternative splicing of this gene results in multiple transcript variants. Considerable variability exists in the I-band, the M-line and the Z-disc regions of titin. Variability in the I-band region contributes to the differences in elasticity of different titin isoforms and, therefore, to the differences in elasticity of different muscle types. Mutations in this gene are associated with familial hypertrophic cardiomyopathy 9, and autoantibodies to titin are produced in patients with the autoimmune disease scleroderma. [provided by RefSeq, Feb 2012].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.